ASP Isotopes closes IPO of 1.25M shares at $4.00, raising $5.0M gross; listed on Nasdaq

ASP Isotopes Inc.

Closed IPO of 1,250,000 shares of common stock at $4.00/share for aggregate gross proceeds of $5.0M.
Shares began trading on Nasdaq Capital Market on Nov 10, 2022 under ticker ASPI.
Underwriters have 45-day over-allotment option to purchase up to 187,500 additional shares at $4.00.
Net proceeds to be used to complete Molybdenum enrichment facility in Pretoria, South Africa and for general corporate purposes.
Revere Securities LLC acted as sole book-running manager for the offering.

item 1.01 item 7.01 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ASP Isotopes Inc. entered into Underwriting Agreement with Revere Securities LLC (effective 2022-11-09).

Action: entry
Agreement: underwriting
Counterparty: Revere Securities LLC
Effective: 2022-11-09

Exact text from the filing

On November 9, 2022, ASP Isotopes Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Revere Securities LLC, as representative of the several underwriters identified therein (the “Underwriters”), relating to the public offering (the “Offering”) of 1,250,000 shares of the Company’s common stock (the “Shares”) by the Company.

View on SEC.gov

Browse all material agreements →

ASP Isotopes Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-073229

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.